Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22Neoplasms 13Colonic Neoplasms 10Breast Neoplasms 10Venous Thromboembolism 8Prostatic Neoplasms 8Multiple Myeloma 7Recurrence 6Polycythemia Vera 6Carcinoma, Non-Small-Cell Lung 6Thrombocythemia, Essential 4Neoplasms, Plasma Cell 4Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Thrombosis 2Sarcoma 2Rectal Neoplasms 2Primary Myelofibrosis 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms by Site 2Myocardial Infarction 2Lung Neoplasms 2Intestinal Neoplasms 2Intestinal Diseases 2Inflammation 2Gastrointestinal Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Neuropsychological Tests 4Walking 3Memantine 3Tablets 2Standard of Care 2Patient Reported Outcome Measures 2Methods 2Electroencephalography 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lime 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Surveys and Questionnaires 1Sugars 1Sodium Chloride 1Sirolimus 1Silymarin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cognitive Dysfunction × Aspirin × Clear all
NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Peking Union Medical College Hospital

Phase 2 Unknown
98 enrolled

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡